Pujade-Lauraine, E., Hilpert, F., Weber, B., Reuss, A., Poveda, A., Kristensen, G., et al. (2014) Bevacizumab Combined with Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer The AURELIA Open-Label Randomized Phase III Trial. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology, Published Online. - References

Browse Menu >>

Browse Subjects >>

Computer Science & Communications

Earth & Environmental Sciences

Social Sciences & Humanities

Why Us? >>

- Open Access
- Peer-reviewed
- Rapid publication
- Lifetime hosting
- Free indexing service
- Free promotion service
- More citations
- Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

Contact Us >>

customer@scirp.org

+86 18163351462(WhatsApp)

1655362766

Paper Publishing WeChat

Book Publishing WeChat

(or Email:book@scirp.org)

Article citations
More>>

Pujade-Lauraine, E., Hilpert, F., Weber, B., Reuss, A., Poveda, A., Kristensen, G., et al. (2014) Bevacizumab Combined with Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, Published Online.

has been cited by the following article:

TITLE: Current Possible Drug Therapies for Ovarian Cancer

AUTHORS: Jungyeob Seoung, Young-Han Park, Chaechun Rhim, Sungju Kim

KEYWORDS: Ovarian Cancer, Intraperitoneal Chemotherapy, Targeting Therapy

JOURNAL NAME: Journal of Cancer Therapy, Vol.5 No.13, November 7, 2014

ABSTRACT: Ovarian cancer is the most aggressive gynecologic cancer of the heterogenous phenotypes. Development of the new chemotherapeutic agents and drug delivery mode makes better outcomes for patient treatments. Optimal cytoreductive therapy followed by molecular targeting therapy, intraperitoneal chemotherapy and dose dense chemotherapy is a hot therapeutic concept in ovarian cancers. In our review, we will introduce recent therapeutic advances in epithelial ovarian cancer patients.

Open Access

A Pilot Study of Gemcitabine and Epirubicin Combination Chemotherapy as a Salvage Regimen for Recurrent Platinum Resistant and/or Refractory Epithelial Ovarian Cancer

Abd El Halim Abu-Hamar

DOI: 10.4236/jct.2011.24066 4,738 Downloads 7,887 Views Citations

Pub. Date: October 12, 2011

Open Access

Journal News: Osmar Pinto Jr. et al.’s Research Work, Published in American Journal of Climate Change, Has Been Reported by BBC News

AJCC Editorial Board

DOI: 10.4236/ajcc.2014.32011 2,521 Downloads 3,328 Views Citations

Pub. Date: June 20, 2014

Open Access

Erratum to “Novel Wavelet-Based Segmentation of Prostate CBCT Images with Implanted Calypso Transponders” [International Journal of Medical Physics, Clinical Engineering and Radiation Oncology 6 (2017) 336-343]

Yingxia Liu, Ziad Saleh, Yulin Song, Maria Chan, Xiang Li, Chengyu Shi, Xin Qian, Xiaoli Tang

DOI: 10.4236/ijmpcero.2017.64033 626 Downloads 955 Views Citations

Pub. Date: October 19, 2017

Open Access

Efficacy and Safety of PDM011011 Capsules as Compared to Metformin in Subjects with Type-2 Diabetes Mellitus: An Open-Label, Randomized, Active-Controlled, Multicentric, Phase III Study

Ashish C. Suthar, Vikas G. Pai, Yogesh Kadam, Aniruddha Tongaonkar, Shailaja Kale, Atul B. Deshpande, Sharat Kolke, Snehal Tanna, Shrikant V. Deshpande, Purvi Chawla, Debjit Biswas, Somesh Sharma

DOI: 10.4236/jdm.2016.61005 5,397 Downloads 6,522 Views Citations

Pub. Date: February 4, 2016

Open Access

Maintenance Chemotherapy in Ovarian Cancer: A Trial-Sequential Analysis

Andrea Messori, Valeria Fadda, Dario Maratea, Sabrina Trippoli

DOI: 10.4236/jct.2013.47145 4,267 Downloads 5,357 Views Citations

Pub. Date: September 4, 2013

Follow SCIRP